Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$246,241
+$8,039 QoQ
Shares Held
680
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,708
of 3,149 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Autumn Glory Partners, LLC holds $18,776,361 across 8 Drug Manufacturers - General names. AMGN ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
20,874 | $5,301,367 | |
| 2 | NVO |
Novo Nordisk A S
|
99,888 | $4,788,630 | |
| 3 | LLY |
ELI LILLY & Co
|
2,428 | $2,912,215 | |
| 4 | ABBV |
AbbVie Inc.
|
10,875 | $2,736,584 | |
| 5 | PFE |
Pfizer Inc
|
66,212 | $1,594,384 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,251 | $931,753 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,099 | $265,187 | |
| 8 | AMGN |
Amgen Inc
This page
|
680 | $246,241 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,241 | 680 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $238,202 | 677 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $211,442 | 646 | Shares | Sole | 2026-01-27 | |
| 2025-03-31 | $201,261 | 646 | Shares | Sole | 2025-04-21 | |
| 2024-09-30 | $257,123 | 798 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $201,842 | 646 | Shares | Sole | 2024-08-01 | |
| 2023-09-30 | $224,683 | 836 | Shares | Sole | 2023-11-01 | |
| 2021-12-31 | $300,559 | 1,336 | Shares | Sole | 2022-02-16 | |
| No filing history on record for this holder in this stock. | ||||||